Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,664 JPY | +1.87% | +1.93% | +1.15% |
Apr. 25 | AstraZeneca upbeat as cancer drugs underpin sales growth | AN |
Apr. 08 | AstraZeneca hails neurological data for Ultomiris, Soliris | AN |
Evolution of the average Target Price on Sankyo Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- 6417 Stock
- Consensus Sankyo Co., Ltd.